Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,585-7,596 of 10,612

Drug study icon

CompletedNCT00841269

Oral Uridine for Treatment of Depression in bipolarity in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 13 Years to 18 Years

Countries: United States
Sponsor: University of Utah
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00330551

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia

Behavioral study icon

SuspendedNCT05935644

ORCHID: An Online Intervention for Persons With HIV (Miami)

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

DepressionBehavioralFrom 18 Years to 90 Years

Countries: United States
Sponsor: University of Miami
Condition: Depression

Behavioral study icon

CompletedNCT05656534

Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Ohio State University
Condition: Addiction

Drug study icon

WithdrawnNCT00425815

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia

Behavioral study icon

CompletedNCT05736211

Organization-level Youth Engagement Approach for Substance Misuse Prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 11 Years

Countries: United States
Sponsor: Wake Forest University Health Sciences
Condition: Addiction

Behavioral study icon

CompletedNCT02663986

Organizational Skill Training (OST) in Schools

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 8 Years to 11 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: ADHD

Behavioral study icon

CompletedNCT01176136

Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 11 Years to 15 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: ADHD

Behavioral study icon

CompletedNCT00381407

Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 8 Years to 11 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: ADHD

Drug study icon

WithdrawnNCT03761953

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

CompletedNCT02215538

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Utah
Condition: ADHD

Drug study icon

CompletedNCT01000493

Orvepitant (GW823296) in Adult PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: GlaxoSmithKline
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.